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Adrenodoxin stimulated the oxidation of NADPH by 1,4-benzoquinone, catalyzed by NADPH:adrenodoxin reductase. It prevented the enzyme 
inhibition by NADPH and formed an additional pathway of benzoquinone reduction presumably via reduced adrenodoxin. In the presence of 
100-400 PM NADP+, which increased the K, of NADPH, adrenodoxin acted as a partial competitive inhibitor for NADPH decreasing its TN/K,,, 
by a limiting factor of 3. Ki of adrenodoxin decreased on the NADP+ concentration decrease and was estimated to be about lO-B M in the absence 
of NADP+ 
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1. INTRODUCTION 
Flavoprotein NADPH : adrenodoxin reductase (E.C. 
1.18.1.2) functions in the mitochondrial electron trans- 
port chain for cytochrome P-450-dependent steroid hy- 
droxylation. It donates the electrons to Fe&-protein 
adrenodoxin which further transfers them to cyto- 
chromes P-450scc or P-45Ornr [11. Adrenodoxin reduc- 
tase (ADR) and adrenodoxin (ADX) form a stable 
stoichiometric complex, the stability of which depends 
on the ionic strength, medium composition and oxida- 
tion state of proteins [2-51. Cysteine, histidine and 
arginine residues are essential for NADP(H) binding by 
ADR [6,7], and a lysine residue is located at the ADX- 
binding site [8]. It is assumed that the- reduced ADR- 
NADP+ complex is the form of the enzyme transferring 
an electron to ADX [5]. The evidence available in- 
dicates that the ADX-binding domain is distinct from 
the pyridine nucleotide binding site [l]. 
The formation of a ternary NADP+-flavoprotein- 
ferredoxin complex was demonstrated for ferredox- 
in : NADP+ reductase [9, lo], which possesses a catalytic 
mechanism similar to that of ADR. However, a nega- 
tive cooperativity between NADP(H) and ferredoxin 
binding was assumed on the basis of kinetic and dif- 
ference spectroscopy data [9, lo]. 
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In this paper we present he evidence from the steady- 
state kinetic data on the existence of the negative co- 
operativity between NADPH and ADX binding to 
NADPH : adrenodoxin reductase. 
2. MATERIALS AND METHODS 
Adrenodoxin (A414/A280 = 0.83) and adrenodoxin reductase 
(A&Aw, = 7.7) were prepared from bovine adrenal mitochondria 
[l 11. The concentrations of ADX and ADR were determined spectro- 
photometrically with the use of 6414 = 10 mM-‘cm-’ and 6450 =
11 mM-‘cm-‘, respectively. NADPH, NADP+, cytochrome c (Ser- 
va) were used without further purification. 1,4-Benzoquinone 
(Reakhim, USSR) was purified by sublimation in vacuum. The reac- 
tion rate was determined spectrophotometrically using a Hitachi-557 
spectrophotometer at25 * 0.1 “C to the NADPH absorption decrease 
(46340 = 6.2 mM-‘cm-‘). The rate of nonenxymatic NADPH oxida- 
tion by BQ never exceeded 3% of the total reaction rate and was sub- 
tracted from it. The ADX-linked reduction of cytochrome c was 
monitored using Aaso = 20 mM-‘cm-‘. Cytochrome c concentration 
was 40 ,uM. 0.1 M K-phosphate solution (pH 7.0) containing 1 mM 
EDTA was used.TN, with an exception of cytochrome c reduction, 
corresponds to a number of NADPH consumed by FAD per 1 s. 
3. RESULTS AND DISCUSSION 
The data on the initial rates of ADR-catalyzed 
NADPH oxidation by benzoquinone linearize the 
Lineweaver-Burke coordinates (fig. 1). TN of the reac- 
tion makes up 22-25 s-l when lo-30pM of NADPH 
are used. The data are in accordance with the reported 
low values of the K,,, of NADPH (1.8-2.5 pM [12,13]) 
and TN is close to 28 s-’ corresponding to the maximal 
rate of enzyme reduction by NADPH 131. TN/K,,, for 
BQ diminishes on the NADPH concentration increase. 
NADPH is supposed to be a competitive inhibitor for 
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Fig. 1. The dependence of the initial rate of ADR-catalyzed oxidation 
of NADPH by benzoquinone on the substrate concentrations. 
NADPH concentrations: 28 PM (l), 22 ,uM (2), 16.5 CM (3), 9.7 FM 
(4), and 22/tM NADPH in the presence of 0.5 PM adrenodoxin (5). 
quinoidal electron acceptors {14], and the Ki of 
NADPH, estimated from the dependence of the slopes 
of the Lineweaver-Burke plots (fig.1) on the NADPH 
concentrations is close to 5 /IM. TN/K, for BQ, obtain- 
ed by extrapolation to zero concentrations of NADPH, 
makes up 6.5 - 10’ M-is-‘. One must note, that the in- 
hibition is incomplete and the reaction rate drops to a 
constant value at NADPH concentrations exceeding 
50 PM. These results explain previously reported low 
diaphorase activities of ADR [2,3]. However, our data 
do not allow to conclude, whether the inhibition reflects 
the displacement of NADP+ from its complex with re- 
duced ADR [3] or the presence of a second 
NADP+/NADPH binding site 1131. 
Addition of ADX increases the reaction rate. TN is 
close to 20 s-r (fig.l), and the rate does not depend on 
the NADPH concentration (lo-30 FM, data not 
shown). At low BQ concentrations the break is ob- 
served in the Lineweaver-Burke plot, and TNof the sec- 
ond ‘slow’ phase in the range 3.5-5 s-r may be estimat- 
ed (fig. 1). This biphasicity may be caused by the BQ re- 
duction via adrenodoxin, since at 0.5 pM of ADX the 
rate of ADX-linked cytochrome c reduction by ADR is 
8 s-i (on a one-electron basis). Analogous breaks are 
also characteristic of yeast flavocytochrome bz, where 
quinoidal acceptors oxidize the heme at a higher rate 
constant than FMNH2, but the electron transfer from 
FMNH:! to heme is slower than the FMN reduction by 
lactate [15]. Thus, ADX prevents the reductase inhibi- 
tion by NADPH and probably takes part in the reduc- 
tion of quinone. 
Further experiments were performed at relatively 
high BQ concentrations where the influence of possible 
side reactions might be less. The data of fig.2 indicate 
that 0.1-0.6 FM of ADX give almost the same ac- 
tivating effect. It is not possible to conclude whether 
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Fig.2. The rate of enzymatic oxidation of NADPH by 50 PM benzo- 
quinone in the absence (1) and presence (2) of adrenodoxin. ADX 
concentrations: 0.1 pM (0), 0.3 PM (A), 0.6 pM (of. 
ADX affects the affinity of ADR for NADPH in this 
case, since the K,,, of NADPH is too low. For this 
reason the large concentrations of NADP+ which in- 
creased the Km of NADPH were used. The data of fig.3 
indicate that in the presence of 400 FM NADP+ TN/Km 
for NADPH is close to 3 * ld M-is-‘. Since NADP+ is 
known to be a competitive inhibitor for NADPH pos- 
sessing a Ki close to 10 pM [13] it corresponds to about 
a 40-fold decrease of TN/K,,,. In the presence of 
NADP+ adrenodoxin decreased TN/Km for NADPH 
and to some extent raised TN (fig.3). However, the 
almost constant values of TN/Km were reached at suffi- 
ciently high ADX concentrations (fig.4). This is valid 
for all concentrations of NADP+ tested. Ki for ADX, 
estimated from fig.4, was close to 0.4 ,uM at 400 FM of 
NADP+. It is evident that Ki decreased on the NADP+ 
concentration decrease and diminished about 4-fold 
when 1OOyM of NADP+ were used. 
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Fig.3. The effect of adrenodoxin on the rate of ADR-catalyzed 
NADPH oxidation by 50pM benzoquinone in the presence of 
4OOyM NADP’. Adrenodoxin concentratjons: 0 (I), 0.1 CM (2), 
0.2 pM (3), 0.4 pM (4) and 6 ,sM (5). 
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Fig.4. The effect of adrenodoxin on TN/K,,, for NADPH in the pres- 
ence of 100 PM (l), 200 CM (2) and 400 pM NADP+ (3). 
The data of figs 3 and 4 demonstrate a negative co- 
operativity between the ADX and NADPH binding and 
indicate that ADX decreases the affinity of ADR for 
NADPH by a limiting factor of 3. This value is several- 
fold less than that reported for ferredoxin : NADP+ re- 
ductase [9]. Since ADX does not change the standard 
potential of reductase [5] the change in affinity is prob- 
ably due to induced sterical hindrances or a partial over- 
lapping of binding domains. The increase of TN at fix- 
ed BQ concentrations on adrenodoxin binding (fig.3) 
evidences a rather complex influence of ADX on cata- 
lytic properties of reductase. 
It is evident from fig.4 that NADP+ decreases the 
ADR affinity for ADX. One may assume that the Ki of 
ADX, obtained from these data, corresponds to the Kd 
of the ADR-oxidized ADX complex at the given 
NADP+ concentration. However, it seems that the lim- 
iting value of Kd is not reached at these NADP+ concen- 
trations (fig.4). Again, assuming that the Kd of the ox- 
idized ADR-NADP+ complex, which corresponds to 
the competitive Ki for NADPH, is close to lo-’ M 
[3,13,16] one may suggest that the Kd of the ADR-ADX 
complex is increased about 40-fold at 400 ,uM of 
NADP+. Thus, & of this complex must be close to 
10m8 M. It is consistent with the value of 10v9 M, esti- 
mated from the ADX-stimulated diaphorase reaction of 
ADR at a significantly lower ionic strength [2]. 
REFERENCES 
111 
t21 
131 
141 
151 
WI 
171 
PI 
t91 
t101 
illI 
WI 
[I31 
1141 
t151 
1161 
Lambeth, J.D., Seybert, D.W., Lancaster, J.R., Salerno, J.C. 
and Kamin, H. (1982) Mol. Cell. Biochem. 45, 13-31. 
Chu, J.-W. and Kimura, T. (1973) J. Biol. Chem. 248, 
5183-5187. 
Lambeth, J.D. and Kamin, H. (1976) J. Biol. Chem. 251, 
4299-4306. 
Lambeth, J.D., McCaslin, D.R. and Kamin, H. (1976) J. Biol. 
Chem. 251, 7545-7550. 
Lambeth, J.D., Seybert, D.W. and Kamin, H. (1979) J. Biol. 
Chem. 254, 7255-7264. 
Hiwatashi, A., Ichikawa, Y., Yamano, T. and Maruya, N. 
(1976) Biochemistry 15, 3091-3097. 
Nonaka, Y., Sugiyama, T. and Yamano, T. (1982) J. Biochem. 
92, 1693-1701. 
Hamamoto, I. and Ichikawa, Y. (1984) Biochim. Biophys. Acta 
786, 32-41. 
Batie, C.J. and Kamin, H. (1984) J. Biol. Chem. 259, 
8832-8839. 
Batie, C.J. and Kamin, H. (1984) J. Biol. Chem. 259, 
11976-11985. 
Usanov, S.A., Turko, I.V., Chashchin, V.L. and Akhrem, A.A. 
(1985) B&him. Biophys. Acta 832, 288-296. 
Chu, J.-W. and Kimura, T. (1973) J. Biol. Chem. 248, 
2089-2094. 
Lambeth, J.D. and Kamin, H. (1977) J. Biol. Chem. 252, 
2908-2917. 
C&as, N.K., MarcinkeviEiene, J.A., Kulys, J.J. and Usanov, 
S.A. (1987) Biokhimiya 52, 643-649. 
C&as, N.K., Pocius, A.K., Butkus, A.A., Kulys, J.J. and 
AntanaviEius, V.S. (1986) Biokhimiya 51, 285-292. 
Nonaka, Y., Fujii, S. and Yamano, T. (1985) J. Biochem. 97, 
1263-1271. 
340 
